BioSpace News Archive

According to QY Research Medical, the nanomedicine market size was estimated at $171,695.33 million in 2020 and is expected to surpass $393,046.52 million by 2030, registering a CAGR of 9.5% from 2021 to 2030.

The global Next Generation Diabetes Therapy and Drug Delivery Market size was reached at $7.1 billion in 2020, and is expected to hit $28.0 billion by 2030, growing at a CAGR of 14.28% from 2021 to 2030.

According to QY Research Medical, the nose reconstruction market size is expected to reach around $6.1 billion by 2030 and growing at a registered CAGR of 6.8% from 2021 to 2030.

The global ostomy drainage bags market is expected to witness growth at a CAGR of 4% from 2021 to 2030 and to reach $2,409.38 million by 2030.

G1 Therapeutics, Inc. (Nasdaq: GTHX), today announced results of a post-hoc study analysis showing that ES-SCLC patients who received trilaciclib prior to chemotherapy had a lower incidence of single- and multilineage myelosuppressive events—fewer cases of severe neutropenia, severe anemia, and severe thrombocytopenia—compared to patients receiving placebo.

According to QY Research Medical, the refurbished DNA sequencing platforms market size was estimated at $89.83 million in 2020, and is expected to reach $129.61 million by 2030, registering a CAGR of 2.6% from 2021 to 2030.

Cingulate Inc. announced that Chairman and CEO Shane J. Schaffer, PharmD, and preeminent board-certified psychiatrist and Cingulate scientific advisor Dr. Ann Childress, MD, will participate in a live Benzinga All Access event on June 3, 2022, at 8:45 a.m. CST.

A mysterious form of diabetes known as malnutrition-related diabetes afflicts tens of millions of people in Asian and sub-Saharan African countries.

Immunicom, Inc., a privately held clinical-stage biotechnology company with a transformative immuno-oncology platform, presented data from its ongoing clinical investigation [NCT04004910] at the American Society of Clinical Oncology’s (ASCO) 2022 Annual Meeting.

LianBio, a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, announced that members of the management team will participate in fireside chats at the following upcoming investor conferences.